CD8A and neoplasm: This targeted approach enhances drug accumulation in the tumortissue, stimulated tumor-infiltrating CD8+ T and NK cells,and resulted in a dose-dependent reduction of tumor growth.253 This innovative strategy holds promise forimproving the efficacy and specificity of cancer therapeutics.